Long Term Outcomes of Hyperemic Stenosis Resistance Index (HSR) in Patients with Stable Chronic Angina

The hyperemic stenosis resistance index (HSR) was introduced as a more complete hemodynamic severity indicator of a coronary lesion. HSR combines both pressure drop across a lesion and the flow through it, therefore overcoming the limitations of traditional indices such as fractional flow reserve (FFR) and coronary flow reserve (CFR).

Pronóstico al año en lesiones ateroscleróticas vs las no ateroscleróticas en pacientes con MINOCA

The aim of this multicenter study was to assess the diagnostic and prognostic value of HSR, as well as clinical outcomes.  Primary end point was target vessel failure (TVF), defined as combination of cardiac death, myocardial infarction (AMI) and clinically driven target vessel revascularization.

It included a total 853 patients with 1,107 vessels. Patient mean age was 63 and they were mostly men. The most assessed vessel was the anterior descending artery (57%), followed by the circumflex (24%) and the right coronary (19%). HSR identified more accurately the presence of inducible ischemia vs. FFR and CFR (area under the curve 0,71 vs 0,66 and 0,62, respectively; p<0,005 for both).

Read also: BIONYX: Onyx vs. Orsiro At 5 Years.

An abnormal HSR measurement was an independent and important predictor of target vessel failure at 5 year followup (HR 3,80, CI 95%: 2,12-6,73; p<0,005). On deferred vessels, HSR seems to identify more accurately those that could benefit from revascularization, vs FFR and / or CFR. 

Conclusion

The present study confirms the diagnostic value of HSR for to detect ischemia in coronary lesions. This registry is the first to show the prognostic importance of HSR based on long term risk of TVF. We need more prospective studies to confirm these findings.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Membro do Conselho Editorial da SOLACI.org.

Título Original: Impact of hyperaemic stenosis resistance on long-term outcomes of stable angina in the ILIAS Registry.

Referência: Coen K.M. Boerhout , MD et al EuroIntervention 2024;20:e699-e706.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...